Global TROP2-ADC Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Trop-2, the full name of which is human trophoblast surface antigen, was first discovered in human trophoblast cells in 1981. Trop-2 is a type I transmembrane glycoprotein consisting of 323 amino acids. Its structure consists of a large extracellular region, a single transmembrane region, and a short cytoplasmic tail. The extracellular region has four N-glycosylation sites containing extracellular epidermal growth factor repeat sequences, including a cysteine-rich domain, a thyroglobulin-1 domain, and a cysteine-deficient domain.
The global TROP2-ADC Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “TROP2-ADC Drug Industry Forecast” looks at past sales and reviews total world TROP2-ADC Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected TROP2-ADC Drug sales for 2024 through 2030. With TROP2-ADC Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TROP2-ADC Drug industry.
This Insight Report provides a comprehensive analysis of the global TROP2-ADC Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TROP2-ADC Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TROP2-ADC Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TROP2-ADC Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TROP2-ADC Drug.
United States market for TROP2-ADC Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TROP2-ADC Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TROP2-ADC Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TROP2-ADC Drug players cover Merck, AstraZeneca, Duoxi Biotech, Kelun Biotech, Shijian Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TROP2-ADC Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global TROP2-ADC Drug market?
What factors are driving TROP2-ADC Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TROP2-ADC Drug market opportunities vary by end market size?
How does TROP2-ADC Drug break out by Type, by Application?
Trop-2, the full name of which is human trophoblast surface antigen, was first discovered in human trophoblast cells in 1981. Trop-2 is a type I transmembrane glycoprotein consisting of 323 amino acids. Its structure consists of a large extracellular region, a single transmembrane region, and a short cytoplasmic tail. The extracellular region has four N-glycosylation sites containing extracellular epidermal growth factor repeat sequences, including a cysteine-rich domain, a thyroglobulin-1 domain, and a cysteine-deficient domain.
The global TROP2-ADC Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “TROP2-ADC Drug Industry Forecast” looks at past sales and reviews total world TROP2-ADC Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected TROP2-ADC Drug sales for 2024 through 2030. With TROP2-ADC Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TROP2-ADC Drug industry.
This Insight Report provides a comprehensive analysis of the global TROP2-ADC Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TROP2-ADC Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TROP2-ADC Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TROP2-ADC Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TROP2-ADC Drug.
United States market for TROP2-ADC Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TROP2-ADC Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TROP2-ADC Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TROP2-ADC Drug players cover Merck, AstraZeneca, Duoxi Biotech, Kelun Biotech, Shijian Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TROP2-ADC Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Clinical Drugs
- Marketed Drugs
- Hematological Tumors
- Solid Tumors
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- AstraZeneca
- Duoxi Biotech
- Kelun Biotech
- Shijian Biotech
- Gilead
- LegoChem Biosciences
- Chiome Bioscience
- BiOneCure Therapeutics
- DualityBio
What is the 10-year outlook for the global TROP2-ADC Drug market?
What factors are driving TROP2-ADC Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TROP2-ADC Drug market opportunities vary by end market size?
How does TROP2-ADC Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TROP2-ADC Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for TROP2-ADC Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for TROP2-ADC Drug by Country/Region, 2019, 2023 & 2030
2.2 TROP2-ADC Drug Segment by Type
2.2.1 Clinical Drugs
2.2.2 Marketed Drugs
2.3 TROP2-ADC Drug Sales by Type
2.3.1 Global TROP2-ADC Drug Sales Market Share by Type (2019-2024)
2.3.2 Global TROP2-ADC Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global TROP2-ADC Drug Sale Price by Type (2019-2024)
2.4 TROP2-ADC Drug Segment by Application
2.4.1 Hematological Tumors
2.4.2 Solid Tumors
2.5 TROP2-ADC Drug Sales by Application
2.5.1 Global TROP2-ADC Drug Sale Market Share by Application (2019-2024)
2.5.2 Global TROP2-ADC Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global TROP2-ADC Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global TROP2-ADC Drug Breakdown Data by Company
3.1.1 Global TROP2-ADC Drug Annual Sales by Company (2019-2024)
3.1.2 Global TROP2-ADC Drug Sales Market Share by Company (2019-2024)
3.2 Global TROP2-ADC Drug Annual Revenue by Company (2019-2024)
3.2.1 Global TROP2-ADC Drug Revenue by Company (2019-2024)
3.2.2 Global TROP2-ADC Drug Revenue Market Share by Company (2019-2024)
3.3 Global TROP2-ADC Drug Sale Price by Company
3.4 Key Manufacturers TROP2-ADC Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TROP2-ADC Drug Product Location Distribution
3.4.2 Players TROP2-ADC Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TROP2-ADC DRUG BY GEOGRAPHIC REGION
4.1 World Historic TROP2-ADC Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global TROP2-ADC Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global TROP2-ADC Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic TROP2-ADC Drug Market Size by Country/Region (2019-2024)
4.2.1 Global TROP2-ADC Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global TROP2-ADC Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas TROP2-ADC Drug Sales Growth
4.4 APAC TROP2-ADC Drug Sales Growth
4.5 Europe TROP2-ADC Drug Sales Growth
4.6 Middle East & Africa TROP2-ADC Drug Sales Growth
5 AMERICAS
5.1 Americas TROP2-ADC Drug Sales by Country
5.1.1 Americas TROP2-ADC Drug Sales by Country (2019-2024)
5.1.2 Americas TROP2-ADC Drug Revenue by Country (2019-2024)
5.2 Americas TROP2-ADC Drug Sales by Type (2019-2024)
5.3 Americas TROP2-ADC Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TROP2-ADC Drug Sales by Region
6.1.1 APAC TROP2-ADC Drug Sales by Region (2019-2024)
6.1.2 APAC TROP2-ADC Drug Revenue by Region (2019-2024)
6.2 APAC TROP2-ADC Drug Sales by Type (2019-2024)
6.3 APAC TROP2-ADC Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TROP2-ADC Drug by Country
7.1.1 Europe TROP2-ADC Drug Sales by Country (2019-2024)
7.1.2 Europe TROP2-ADC Drug Revenue by Country (2019-2024)
7.2 Europe TROP2-ADC Drug Sales by Type (2019-2024)
7.3 Europe TROP2-ADC Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TROP2-ADC Drug by Country
8.1.1 Middle East & Africa TROP2-ADC Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa TROP2-ADC Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa TROP2-ADC Drug Sales by Type (2019-2024)
8.3 Middle East & Africa TROP2-ADC Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TROP2-ADC Drug
10.3 Manufacturing Process Analysis of TROP2-ADC Drug
10.4 Industry Chain Structure of TROP2-ADC Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TROP2-ADC Drug Distributors
11.3 TROP2-ADC Drug Customer
12 WORLD FORECAST REVIEW FOR TROP2-ADC DRUG BY GEOGRAPHIC REGION
12.1 Global TROP2-ADC Drug Market Size Forecast by Region
12.1.1 Global TROP2-ADC Drug Forecast by Region (2025-2030)
12.1.2 Global TROP2-ADC Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global TROP2-ADC Drug Forecast by Type (2025-2030)
12.7 Global TROP2-ADC Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck TROP2-ADC Drug Product Portfolios and Specifications
13.1.3 Merck TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca TROP2-ADC Drug Product Portfolios and Specifications
13.2.3 AstraZeneca TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Duoxi Biotech
13.3.1 Duoxi Biotech Company Information
13.3.2 Duoxi Biotech TROP2-ADC Drug Product Portfolios and Specifications
13.3.3 Duoxi Biotech TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Duoxi Biotech Main Business Overview
13.3.5 Duoxi Biotech Latest Developments
13.4 Kelun Biotech
13.4.1 Kelun Biotech Company Information
13.4.2 Kelun Biotech TROP2-ADC Drug Product Portfolios and Specifications
13.4.3 Kelun Biotech TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Kelun Biotech Main Business Overview
13.4.5 Kelun Biotech Latest Developments
13.5 Shijian Biotech
13.5.1 Shijian Biotech Company Information
13.5.2 Shijian Biotech TROP2-ADC Drug Product Portfolios and Specifications
13.5.3 Shijian Biotech TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shijian Biotech Main Business Overview
13.5.5 Shijian Biotech Latest Developments
13.6 Gilead
13.6.1 Gilead Company Information
13.6.2 Gilead TROP2-ADC Drug Product Portfolios and Specifications
13.6.3 Gilead TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Gilead Main Business Overview
13.6.5 Gilead Latest Developments
13.7 LegoChem Biosciences
13.7.1 LegoChem Biosciences Company Information
13.7.2 LegoChem Biosciences TROP2-ADC Drug Product Portfolios and Specifications
13.7.3 LegoChem Biosciences TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 LegoChem Biosciences Main Business Overview
13.7.5 LegoChem Biosciences Latest Developments
13.8 Chiome Bioscience
13.8.1 Chiome Bioscience Company Information
13.8.2 Chiome Bioscience TROP2-ADC Drug Product Portfolios and Specifications
13.8.3 Chiome Bioscience TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Chiome Bioscience Main Business Overview
13.8.5 Chiome Bioscience Latest Developments
13.9 BiOneCure Therapeutics
13.9.1 BiOneCure Therapeutics Company Information
13.9.2 BiOneCure Therapeutics TROP2-ADC Drug Product Portfolios and Specifications
13.9.3 BiOneCure Therapeutics TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 BiOneCure Therapeutics Main Business Overview
13.9.5 BiOneCure Therapeutics Latest Developments
13.10 DualityBio
13.10.1 DualityBio Company Information
13.10.2 DualityBio TROP2-ADC Drug Product Portfolios and Specifications
13.10.3 DualityBio TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 DualityBio Main Business Overview
13.10.5 DualityBio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TROP2-ADC Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for TROP2-ADC Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for TROP2-ADC Drug by Country/Region, 2019, 2023 & 2030
2.2 TROP2-ADC Drug Segment by Type
2.2.1 Clinical Drugs
2.2.2 Marketed Drugs
2.3 TROP2-ADC Drug Sales by Type
2.3.1 Global TROP2-ADC Drug Sales Market Share by Type (2019-2024)
2.3.2 Global TROP2-ADC Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global TROP2-ADC Drug Sale Price by Type (2019-2024)
2.4 TROP2-ADC Drug Segment by Application
2.4.1 Hematological Tumors
2.4.2 Solid Tumors
2.5 TROP2-ADC Drug Sales by Application
2.5.1 Global TROP2-ADC Drug Sale Market Share by Application (2019-2024)
2.5.2 Global TROP2-ADC Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global TROP2-ADC Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global TROP2-ADC Drug Breakdown Data by Company
3.1.1 Global TROP2-ADC Drug Annual Sales by Company (2019-2024)
3.1.2 Global TROP2-ADC Drug Sales Market Share by Company (2019-2024)
3.2 Global TROP2-ADC Drug Annual Revenue by Company (2019-2024)
3.2.1 Global TROP2-ADC Drug Revenue by Company (2019-2024)
3.2.2 Global TROP2-ADC Drug Revenue Market Share by Company (2019-2024)
3.3 Global TROP2-ADC Drug Sale Price by Company
3.4 Key Manufacturers TROP2-ADC Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TROP2-ADC Drug Product Location Distribution
3.4.2 Players TROP2-ADC Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TROP2-ADC DRUG BY GEOGRAPHIC REGION
4.1 World Historic TROP2-ADC Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global TROP2-ADC Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global TROP2-ADC Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic TROP2-ADC Drug Market Size by Country/Region (2019-2024)
4.2.1 Global TROP2-ADC Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global TROP2-ADC Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas TROP2-ADC Drug Sales Growth
4.4 APAC TROP2-ADC Drug Sales Growth
4.5 Europe TROP2-ADC Drug Sales Growth
4.6 Middle East & Africa TROP2-ADC Drug Sales Growth
5 AMERICAS
5.1 Americas TROP2-ADC Drug Sales by Country
5.1.1 Americas TROP2-ADC Drug Sales by Country (2019-2024)
5.1.2 Americas TROP2-ADC Drug Revenue by Country (2019-2024)
5.2 Americas TROP2-ADC Drug Sales by Type (2019-2024)
5.3 Americas TROP2-ADC Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TROP2-ADC Drug Sales by Region
6.1.1 APAC TROP2-ADC Drug Sales by Region (2019-2024)
6.1.2 APAC TROP2-ADC Drug Revenue by Region (2019-2024)
6.2 APAC TROP2-ADC Drug Sales by Type (2019-2024)
6.3 APAC TROP2-ADC Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TROP2-ADC Drug by Country
7.1.1 Europe TROP2-ADC Drug Sales by Country (2019-2024)
7.1.2 Europe TROP2-ADC Drug Revenue by Country (2019-2024)
7.2 Europe TROP2-ADC Drug Sales by Type (2019-2024)
7.3 Europe TROP2-ADC Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TROP2-ADC Drug by Country
8.1.1 Middle East & Africa TROP2-ADC Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa TROP2-ADC Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa TROP2-ADC Drug Sales by Type (2019-2024)
8.3 Middle East & Africa TROP2-ADC Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TROP2-ADC Drug
10.3 Manufacturing Process Analysis of TROP2-ADC Drug
10.4 Industry Chain Structure of TROP2-ADC Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TROP2-ADC Drug Distributors
11.3 TROP2-ADC Drug Customer
12 WORLD FORECAST REVIEW FOR TROP2-ADC DRUG BY GEOGRAPHIC REGION
12.1 Global TROP2-ADC Drug Market Size Forecast by Region
12.1.1 Global TROP2-ADC Drug Forecast by Region (2025-2030)
12.1.2 Global TROP2-ADC Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global TROP2-ADC Drug Forecast by Type (2025-2030)
12.7 Global TROP2-ADC Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck TROP2-ADC Drug Product Portfolios and Specifications
13.1.3 Merck TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca TROP2-ADC Drug Product Portfolios and Specifications
13.2.3 AstraZeneca TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Duoxi Biotech
13.3.1 Duoxi Biotech Company Information
13.3.2 Duoxi Biotech TROP2-ADC Drug Product Portfolios and Specifications
13.3.3 Duoxi Biotech TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Duoxi Biotech Main Business Overview
13.3.5 Duoxi Biotech Latest Developments
13.4 Kelun Biotech
13.4.1 Kelun Biotech Company Information
13.4.2 Kelun Biotech TROP2-ADC Drug Product Portfolios and Specifications
13.4.3 Kelun Biotech TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Kelun Biotech Main Business Overview
13.4.5 Kelun Biotech Latest Developments
13.5 Shijian Biotech
13.5.1 Shijian Biotech Company Information
13.5.2 Shijian Biotech TROP2-ADC Drug Product Portfolios and Specifications
13.5.3 Shijian Biotech TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shijian Biotech Main Business Overview
13.5.5 Shijian Biotech Latest Developments
13.6 Gilead
13.6.1 Gilead Company Information
13.6.2 Gilead TROP2-ADC Drug Product Portfolios and Specifications
13.6.3 Gilead TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Gilead Main Business Overview
13.6.5 Gilead Latest Developments
13.7 LegoChem Biosciences
13.7.1 LegoChem Biosciences Company Information
13.7.2 LegoChem Biosciences TROP2-ADC Drug Product Portfolios and Specifications
13.7.3 LegoChem Biosciences TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 LegoChem Biosciences Main Business Overview
13.7.5 LegoChem Biosciences Latest Developments
13.8 Chiome Bioscience
13.8.1 Chiome Bioscience Company Information
13.8.2 Chiome Bioscience TROP2-ADC Drug Product Portfolios and Specifications
13.8.3 Chiome Bioscience TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Chiome Bioscience Main Business Overview
13.8.5 Chiome Bioscience Latest Developments
13.9 BiOneCure Therapeutics
13.9.1 BiOneCure Therapeutics Company Information
13.9.2 BiOneCure Therapeutics TROP2-ADC Drug Product Portfolios and Specifications
13.9.3 BiOneCure Therapeutics TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 BiOneCure Therapeutics Main Business Overview
13.9.5 BiOneCure Therapeutics Latest Developments
13.10 DualityBio
13.10.1 DualityBio Company Information
13.10.2 DualityBio TROP2-ADC Drug Product Portfolios and Specifications
13.10.3 DualityBio TROP2-ADC Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 DualityBio Main Business Overview
13.10.5 DualityBio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. TROP2-ADC Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. TROP2-ADC Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Clinical Drugs
Table 4. Major Players of Marketed Drugs
Table 5. Global TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 6. Global TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Table 7. Global TROP2-ADC Drug Revenue by Type (2019-2024) & ($ million)
Table 8. Global TROP2-ADC Drug Revenue Market Share by Type (2019-2024)
Table 9. Global TROP2-ADC Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global TROP2-ADC Drug Sale by Application (2019-2024) & (K Units)
Table 11. Global TROP2-ADC Drug Sale Market Share by Application (2019-2024)
Table 12. Global TROP2-ADC Drug Revenue by Application (2019-2024) & ($ million)
Table 13. Global TROP2-ADC Drug Revenue Market Share by Application (2019-2024)
Table 14. Global TROP2-ADC Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global TROP2-ADC Drug Sales by Company (2019-2024) & (K Units)
Table 16. Global TROP2-ADC Drug Sales Market Share by Company (2019-2024)
Table 17. Global TROP2-ADC Drug Revenue by Company (2019-2024) & ($ millions)
Table 18. Global TROP2-ADC Drug Revenue Market Share by Company (2019-2024)
Table 19. Global TROP2-ADC Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers TROP2-ADC Drug Producing Area Distribution and Sales Area
Table 21. Players TROP2-ADC Drug Products Offered
Table 22. TROP2-ADC Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global TROP2-ADC Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global TROP2-ADC Drug Sales Market Share Geographic Region (2019-2024)
Table 27. Global TROP2-ADC Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global TROP2-ADC Drug Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global TROP2-ADC Drug Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global TROP2-ADC Drug Sales Market Share by Country/Region (2019-2024)
Table 31. Global TROP2-ADC Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global TROP2-ADC Drug Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas TROP2-ADC Drug Sales by Country (2019-2024) & (K Units)
Table 34. Americas TROP2-ADC Drug Sales Market Share by Country (2019-2024)
Table 35. Americas TROP2-ADC Drug Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 37. Americas TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 38. APAC TROP2-ADC Drug Sales by Region (2019-2024) & (K Units)
Table 39. APAC TROP2-ADC Drug Sales Market Share by Region (2019-2024)
Table 40. APAC TROP2-ADC Drug Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 42. APAC TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 43. Europe TROP2-ADC Drug Sales by Country (2019-2024) & (K Units)
Table 44. Europe TROP2-ADC Drug Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 46. Europe TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa TROP2-ADC Drug Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa TROP2-ADC Drug Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of TROP2-ADC Drug
Table 52. Key Market Challenges & Risks of TROP2-ADC Drug
Table 53. Key Industry Trends of TROP2-ADC Drug
Table 54. TROP2-ADC Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. TROP2-ADC Drug Distributors List
Table 57. TROP2-ADC Drug Customer List
Table 58. Global TROP2-ADC Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global TROP2-ADC Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas TROP2-ADC Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas TROP2-ADC Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC TROP2-ADC Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC TROP2-ADC Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe TROP2-ADC Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe TROP2-ADC Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa TROP2-ADC Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa TROP2-ADC Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global TROP2-ADC Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global TROP2-ADC Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global TROP2-ADC Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global TROP2-ADC Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck TROP2-ADC Drug Product Portfolios and Specifications
Table 74. Merck TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. AstraZeneca Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca TROP2-ADC Drug Product Portfolios and Specifications
Table 79. AstraZeneca TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Duoxi Biotech Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Duoxi Biotech TROP2-ADC Drug Product Portfolios and Specifications
Table 84. Duoxi Biotech TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Duoxi Biotech Main Business
Table 86. Duoxi Biotech Latest Developments
Table 87. Kelun Biotech Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Kelun Biotech TROP2-ADC Drug Product Portfolios and Specifications
Table 89. Kelun Biotech TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Kelun Biotech Main Business
Table 91. Kelun Biotech Latest Developments
Table 92. Shijian Biotech Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Shijian Biotech TROP2-ADC Drug Product Portfolios and Specifications
Table 94. Shijian Biotech TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Shijian Biotech Main Business
Table 96. Shijian Biotech Latest Developments
Table 97. Gilead Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Gilead TROP2-ADC Drug Product Portfolios and Specifications
Table 99. Gilead TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Gilead Main Business
Table 101. Gilead Latest Developments
Table 102. LegoChem Biosciences Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. LegoChem Biosciences TROP2-ADC Drug Product Portfolios and Specifications
Table 104. LegoChem Biosciences TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. LegoChem Biosciences Main Business
Table 106. LegoChem Biosciences Latest Developments
Table 107. Chiome Bioscience Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Chiome Bioscience TROP2-ADC Drug Product Portfolios and Specifications
Table 109. Chiome Bioscience TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Chiome Bioscience Main Business
Table 111. Chiome Bioscience Latest Developments
Table 112. BiOneCure Therapeutics Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. BiOneCure Therapeutics TROP2-ADC Drug Product Portfolios and Specifications
Table 114. BiOneCure Therapeutics TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. BiOneCure Therapeutics Main Business
Table 116. BiOneCure Therapeutics Latest Developments
Table 117. DualityBio Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. DualityBio TROP2-ADC Drug Product Portfolios and Specifications
Table 119. DualityBio TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. DualityBio Main Business
Table 121. DualityBio Latest Developments
Table 1. TROP2-ADC Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. TROP2-ADC Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Clinical Drugs
Table 4. Major Players of Marketed Drugs
Table 5. Global TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 6. Global TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Table 7. Global TROP2-ADC Drug Revenue by Type (2019-2024) & ($ million)
Table 8. Global TROP2-ADC Drug Revenue Market Share by Type (2019-2024)
Table 9. Global TROP2-ADC Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global TROP2-ADC Drug Sale by Application (2019-2024) & (K Units)
Table 11. Global TROP2-ADC Drug Sale Market Share by Application (2019-2024)
Table 12. Global TROP2-ADC Drug Revenue by Application (2019-2024) & ($ million)
Table 13. Global TROP2-ADC Drug Revenue Market Share by Application (2019-2024)
Table 14. Global TROP2-ADC Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global TROP2-ADC Drug Sales by Company (2019-2024) & (K Units)
Table 16. Global TROP2-ADC Drug Sales Market Share by Company (2019-2024)
Table 17. Global TROP2-ADC Drug Revenue by Company (2019-2024) & ($ millions)
Table 18. Global TROP2-ADC Drug Revenue Market Share by Company (2019-2024)
Table 19. Global TROP2-ADC Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers TROP2-ADC Drug Producing Area Distribution and Sales Area
Table 21. Players TROP2-ADC Drug Products Offered
Table 22. TROP2-ADC Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global TROP2-ADC Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global TROP2-ADC Drug Sales Market Share Geographic Region (2019-2024)
Table 27. Global TROP2-ADC Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global TROP2-ADC Drug Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global TROP2-ADC Drug Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global TROP2-ADC Drug Sales Market Share by Country/Region (2019-2024)
Table 31. Global TROP2-ADC Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global TROP2-ADC Drug Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas TROP2-ADC Drug Sales by Country (2019-2024) & (K Units)
Table 34. Americas TROP2-ADC Drug Sales Market Share by Country (2019-2024)
Table 35. Americas TROP2-ADC Drug Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 37. Americas TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 38. APAC TROP2-ADC Drug Sales by Region (2019-2024) & (K Units)
Table 39. APAC TROP2-ADC Drug Sales Market Share by Region (2019-2024)
Table 40. APAC TROP2-ADC Drug Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 42. APAC TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 43. Europe TROP2-ADC Drug Sales by Country (2019-2024) & (K Units)
Table 44. Europe TROP2-ADC Drug Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 46. Europe TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa TROP2-ADC Drug Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa TROP2-ADC Drug Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa TROP2-ADC Drug Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa TROP2-ADC Drug Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of TROP2-ADC Drug
Table 52. Key Market Challenges & Risks of TROP2-ADC Drug
Table 53. Key Industry Trends of TROP2-ADC Drug
Table 54. TROP2-ADC Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. TROP2-ADC Drug Distributors List
Table 57. TROP2-ADC Drug Customer List
Table 58. Global TROP2-ADC Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global TROP2-ADC Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas TROP2-ADC Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas TROP2-ADC Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC TROP2-ADC Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC TROP2-ADC Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe TROP2-ADC Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe TROP2-ADC Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa TROP2-ADC Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa TROP2-ADC Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global TROP2-ADC Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global TROP2-ADC Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global TROP2-ADC Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global TROP2-ADC Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Merck Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck TROP2-ADC Drug Product Portfolios and Specifications
Table 74. Merck TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. AstraZeneca Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca TROP2-ADC Drug Product Portfolios and Specifications
Table 79. AstraZeneca TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Duoxi Biotech Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Duoxi Biotech TROP2-ADC Drug Product Portfolios and Specifications
Table 84. Duoxi Biotech TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Duoxi Biotech Main Business
Table 86. Duoxi Biotech Latest Developments
Table 87. Kelun Biotech Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Kelun Biotech TROP2-ADC Drug Product Portfolios and Specifications
Table 89. Kelun Biotech TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Kelun Biotech Main Business
Table 91. Kelun Biotech Latest Developments
Table 92. Shijian Biotech Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Shijian Biotech TROP2-ADC Drug Product Portfolios and Specifications
Table 94. Shijian Biotech TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Shijian Biotech Main Business
Table 96. Shijian Biotech Latest Developments
Table 97. Gilead Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Gilead TROP2-ADC Drug Product Portfolios and Specifications
Table 99. Gilead TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Gilead Main Business
Table 101. Gilead Latest Developments
Table 102. LegoChem Biosciences Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. LegoChem Biosciences TROP2-ADC Drug Product Portfolios and Specifications
Table 104. LegoChem Biosciences TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. LegoChem Biosciences Main Business
Table 106. LegoChem Biosciences Latest Developments
Table 107. Chiome Bioscience Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Chiome Bioscience TROP2-ADC Drug Product Portfolios and Specifications
Table 109. Chiome Bioscience TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Chiome Bioscience Main Business
Table 111. Chiome Bioscience Latest Developments
Table 112. BiOneCure Therapeutics Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. BiOneCure Therapeutics TROP2-ADC Drug Product Portfolios and Specifications
Table 114. BiOneCure Therapeutics TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. BiOneCure Therapeutics Main Business
Table 116. BiOneCure Therapeutics Latest Developments
Table 117. DualityBio Basic Information, TROP2-ADC Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. DualityBio TROP2-ADC Drug Product Portfolios and Specifications
Table 119. DualityBio TROP2-ADC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. DualityBio Main Business
Table 121. DualityBio Latest Developments
LIST OF FIGURES
Figure 1. Picture of TROP2-ADC Drug
Figure 2. TROP2-ADC Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TROP2-ADC Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global TROP2-ADC Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. TROP2-ADC Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. TROP2-ADC Drug Sales Market Share by Country/Region (2023)
Figure 10. TROP2-ADC Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Clinical Drugs
Figure 12. Product Picture of Marketed Drugs
Figure 13. Global TROP2-ADC Drug Sales Market Share by Type in 2023
Figure 14. Global TROP2-ADC Drug Revenue Market Share by Type (2019-2024)
Figure 15. TROP2-ADC Drug Consumed in Hematological Tumors
Figure 16. Global TROP2-ADC Drug Market: Hematological Tumors (2019-2024) & (K Units)
Figure 17. TROP2-ADC Drug Consumed in Solid Tumors
Figure 18. Global TROP2-ADC Drug Market: Solid Tumors (2019-2024) & (K Units)
Figure 19. Global TROP2-ADC Drug Sale Market Share by Application (2023)
Figure 20. Global TROP2-ADC Drug Revenue Market Share by Application in 2023
Figure 21. TROP2-ADC Drug Sales by Company in 2023 (K Units)
Figure 22. Global TROP2-ADC Drug Sales Market Share by Company in 2023
Figure 23. TROP2-ADC Drug Revenue by Company in 2023 ($ millions)
Figure 24. Global TROP2-ADC Drug Revenue Market Share by Company in 2023
Figure 25. Global TROP2-ADC Drug Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global TROP2-ADC Drug Revenue Market Share by Geographic Region in 2023
Figure 27. Americas TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 28. Americas TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 29. APAC TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 30. APAC TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 31. Europe TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 32. Europe TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 35. Americas TROP2-ADC Drug Sales Market Share by Country in 2023
Figure 36. Americas TROP2-ADC Drug Revenue Market Share by Country (2019-2024)
Figure 37. Americas TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 38. Americas TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 39. United States TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC TROP2-ADC Drug Sales Market Share by Region in 2023
Figure 44. APAC TROP2-ADC Drug Revenue Market Share by Region (2019-2024)
Figure 45. APAC TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 46. APAC TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 47. China TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 51. India TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe TROP2-ADC Drug Sales Market Share by Country in 2023
Figure 55. Europe TROP2-ADC Drug Revenue Market Share by Country (2019-2024)
Figure 56. Europe TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 57. Europe TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 58. Germany TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. France TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 60. UK TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa TROP2-ADC Drug Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 66. Egypt TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of TROP2-ADC Drug in 2023
Figure 72. Manufacturing Process Analysis of TROP2-ADC Drug
Figure 73. Industry Chain Structure of TROP2-ADC Drug
Figure 74. Channels of Distribution
Figure 75. Global TROP2-ADC Drug Sales Market Forecast by Region (2025-2030)
Figure 76. Global TROP2-ADC Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global TROP2-ADC Drug Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global TROP2-ADC Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global TROP2-ADC Drug Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global TROP2-ADC Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of TROP2-ADC Drug
Figure 2. TROP2-ADC Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TROP2-ADC Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global TROP2-ADC Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. TROP2-ADC Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. TROP2-ADC Drug Sales Market Share by Country/Region (2023)
Figure 10. TROP2-ADC Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Clinical Drugs
Figure 12. Product Picture of Marketed Drugs
Figure 13. Global TROP2-ADC Drug Sales Market Share by Type in 2023
Figure 14. Global TROP2-ADC Drug Revenue Market Share by Type (2019-2024)
Figure 15. TROP2-ADC Drug Consumed in Hematological Tumors
Figure 16. Global TROP2-ADC Drug Market: Hematological Tumors (2019-2024) & (K Units)
Figure 17. TROP2-ADC Drug Consumed in Solid Tumors
Figure 18. Global TROP2-ADC Drug Market: Solid Tumors (2019-2024) & (K Units)
Figure 19. Global TROP2-ADC Drug Sale Market Share by Application (2023)
Figure 20. Global TROP2-ADC Drug Revenue Market Share by Application in 2023
Figure 21. TROP2-ADC Drug Sales by Company in 2023 (K Units)
Figure 22. Global TROP2-ADC Drug Sales Market Share by Company in 2023
Figure 23. TROP2-ADC Drug Revenue by Company in 2023 ($ millions)
Figure 24. Global TROP2-ADC Drug Revenue Market Share by Company in 2023
Figure 25. Global TROP2-ADC Drug Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global TROP2-ADC Drug Revenue Market Share by Geographic Region in 2023
Figure 27. Americas TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 28. Americas TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 29. APAC TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 30. APAC TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 31. Europe TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 32. Europe TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa TROP2-ADC Drug Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa TROP2-ADC Drug Revenue 2019-2024 ($ millions)
Figure 35. Americas TROP2-ADC Drug Sales Market Share by Country in 2023
Figure 36. Americas TROP2-ADC Drug Revenue Market Share by Country (2019-2024)
Figure 37. Americas TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 38. Americas TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 39. United States TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC TROP2-ADC Drug Sales Market Share by Region in 2023
Figure 44. APAC TROP2-ADC Drug Revenue Market Share by Region (2019-2024)
Figure 45. APAC TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 46. APAC TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 47. China TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 51. India TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe TROP2-ADC Drug Sales Market Share by Country in 2023
Figure 55. Europe TROP2-ADC Drug Revenue Market Share by Country (2019-2024)
Figure 56. Europe TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 57. Europe TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 58. Germany TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. France TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 60. UK TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa TROP2-ADC Drug Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa TROP2-ADC Drug Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa TROP2-ADC Drug Sales Market Share by Application (2019-2024)
Figure 66. Egypt TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries TROP2-ADC Drug Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of TROP2-ADC Drug in 2023
Figure 72. Manufacturing Process Analysis of TROP2-ADC Drug
Figure 73. Industry Chain Structure of TROP2-ADC Drug
Figure 74. Channels of Distribution
Figure 75. Global TROP2-ADC Drug Sales Market Forecast by Region (2025-2030)
Figure 76. Global TROP2-ADC Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global TROP2-ADC Drug Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global TROP2-ADC Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global TROP2-ADC Drug Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global TROP2-ADC Drug Revenue Market Share Forecast by Application (2025-2030)
